Opinion · 1 Dec 2025
Research articlePublished 19 Nov 2017
On the Link between Ellagic Acid and the Immune Balance between Human Mononuclear and Colon Carcinoma Cells
1Laboratory for Immunology and Hematology Research, Rabin Medical Center, Hasharon Hospital, Petah Tiqva, Israel; 2Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pomegranate and particularly its phenolic compound ellagic acid (EA) have been well renowned as a therapeutic remedy for a long list of illnesses including inflammation and cancer. The beneficial activity of EA has been attributed to a number of factors comprising its immunomodulatory effect. Our aim was to examine the effect of EA on the immune relationship between human peripheral blood mononuclear cells (PBMC) and colon cancer cells from two human colon carcinoma cell lines.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Immunology: Current Research.
Editorial · 1 Dec 2025
Auto-inflammatory Disorders: Genetic Causes and Targeted Therapies
Editorial · 1 Dec 2025
Host-Parasite Immunological Arena: An Intricate Balance
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunology: Current Research
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Hanna Bessler”
- BylineArticles whose byline prints “Meir Djaldetti”